Zyban
Zyban Price range: $ 40,00 through $ 210,00
Back to products
Zyloprim
Zyloprim Price range: $ 43,00 through $ 144,00

ZyhCG

Price range: $ 50,00 through $ 300,00

ZyhCG is a high-quality pharmaceutical preparation containing Human Chorionic Gonadotropin (HCG) designed to support various hormonal functions. In women, it is primarily used as a key component in fertility treatments to induce ovulation and improve the chances of successful conception. For men, ZyhCG effectively stimulates natural testosterone production to address conditions such as hypogonadotropic hypogonadism. This medication is also indicated for the treatment of prepubertal cryptorchidism, assisting in the proper development of the male reproductive system. Each vial is manufactured to ensure consistent potency and reliability for patients seeking to restore their reproductive health.

SKU: ZyhCG Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

ZyhCG belongs to a therapeutic class of gonadotropic hormones, containing human chorionic gonadotropin (hCG) as its active substance. This medication is dispensed strictly as a prescription drug (Rx) in accordance with federal and state regulations in the United States.

It is primarily utilized in clinical endocrinology and reproductive medicine to stimulate specific gonadal functions under direct specialist oversight. Administration is performed via intramuscular injection following proper reconstitution of the sterile lyophilized powder.

Parameter Details
Active ingredient Human Chorionic Gonadotropin (hCG)
Therapeutic class Gonadotropin / Endocrine agent
Dosage form Lyophilized powder for intramuscular injection
Route of administration Intramuscular (IM)
Prescription status Prescription drug (Rx only)
Primary purpose Treatment of selected endocrine and reproductive conditions

Clinical Profile and Administration

How the Drug Works and Main Uses

How the drug works: Human chorionic gonadotropin (hCG) shares structural and functional features with luteinizing hormone (LH), which is naturally produced by the anterior pituitary gland. By binding to target LH/hCG receptors on testicular interstitial (Leydig) cells or ovarian luteal cells, hCG activates intracellular signaling pathways. In females, this biological action mimics the mid-cycle LH surge, triggering follicular rupture and ovulation. In males, it stimulates the Leydig cells to synthesize and secrete testosterone, supporting spermatogenesis and secondary sexual development. Because hCG does not possess follicle-stimulating hormone (FSH) activity, its mechanism relies primarily on androgenic and luteinizing activity pathways.

Main uses: Indications for human chorionic gonadotropin include the treatment of prepubertal cryptorchidism not caused by anatomical obstruction, selected cases of hypogonadotropic hypogonadism in males, and the induction of ovulation in anovulatory infertile females whose infertility is secondary to pituitary dysfunction. Any use of hCG for weight management or obesity treatment is explicitly classified as an unapproved off-label practice; federal guidelines highlight that hCG has no proven therapeutic efficacy for weight loss, appetite suppression, or fat redistribution.

Dosing Schedule and Practical Guidance

Dosing schedule: The dosing schedule for ZyhCG is highly individualized and must be established by a qualified healthcare provider based on clinical diagnostics, patient body weight, and specific therapeutic goals. For anovulatory female patients undergoing ovulation induction, dosage regimens usually involve a single injection or timed administrations synchronized with follicular monitoring. In male hypogonadotropic hypogonadism, regimens typically require recurrent intramuscular injections multiple times per week over several months. The reconstituted solution must be drawn into a sterile syringe and administered intramuscularly according to strict aseptic technique. Patients should never alter their dosage without direct instruction from their prescriber.

What happens in the body: Following intramuscular administration, human chorionic gonadotropin is absorbed gradually into systemic circulation. Peak serum concentration levels are reached within several hours to a day post-injection, depending on individual metabolic variability. The elimination profile of hCG follows a biphasic decay curve. Metabolic degradation occurs primarily through hepatic enzymatic processing and renal clearance, with a portion of the intact hormone and its subunits excreted in the urine. Endocrine responses, such as serum testosterone elevation or ovulation, occur within predictable biological windows relative to the injection timing.

If you skip a dose: If a scheduled injection of ZyhCG is missed, the patient should contact their treating clinical team promptly for instructions. Because treatment protocols in fertility care and hormonal replacement rely on precise timing, self-administering a double dose to compensate for a missed injection is strictly advised against. Healthcare providers will determine whether to adjust the current schedule or modify the treatment timeline based on patient monitoring.

Storage and expiration: Unreconstituted vials of ZyhCG powder should be stored according to package instructions, typically at controlled room temperature protected from light and excessive moisture. Once reconstituted with the provided sterile diluent, the liquid solution must be refrigerated immediately between 36°F and 46°F (2°C to 8°C) and used within the timeframe designated by the prescription label. Any solution showing turbidity, discoloration, or particulate matter must be safely discarded. Keep out of reach of children.

Safety Information and FAQ

Adverse Reactions and Safety Precautions

What not to combine: ZyhCG may interact with concurrent hormonal therapies or fertility regimens. Combining hCG with other ovulation-inducing agents, such as menotropins or clomiphene citrate, requires careful monitoring due to an increased risk of ovarian hyperstimulation. Concurrent administration with systemic corticosteroids or exogenous androgenic drugs may alter baseline laboratory parameters. Patients must provide their provider with a complete list of prescription medications, non-prescription products, and supplements prior to initiating therapy.

Adverse reactions: Common adverse reactions associated with ZyhCG injections include local reactions at the injection site (such as mild pain, swelling, or redness), headache, fatigue, irritability, and restlessness. In male patients, long-term administration may lead to gynecomastia, fluid retention, or peripheral edema. Female patients may experience mild ovarian enlargement or pelvic discomfort. Any persistent or severe symptoms should be reported to the prescribing physician.

Important precautions: Human chorionic gonadotropin is contraindicated in individuals with a history of hypersensitivity to hCG or any component of the formulation. It is strictly contraindicated in male patients with confirmed or suspected prostatic carcinoma or other androgen-dependent neoplasms. Prepubescent male patients require ongoing clinical monitoring during therapy, as premature epiphyseal closure or precocious puberty can occur. Women receiving hCG for ovulation induction must be monitored for Ovarian Hyperstimulation Syndrome (OHSS), a serious medical condition involving marked pelvic enlargement, fluid accumulation, and systemic complications.

Red flags: Immediate emergency medical attention is required if signs of a severe allergic reaction occur, including facial swelling, swelling of the tongue or throat, or severe breathing difficulties. Female patients must seek emergency care immediately if they develop severe lower abdominal pain, rapid weight gain, persistent nausea, vomiting, or dyspnea, which may indicate severe OHSS. Male patients experiencing sudden chest pain, severe calf swelling, or signs of thromboembolism should get emergency medical help right away.

Special populations: In pregnant women, exogenous hCG therapy is generally contraindicated once pregnancy is confirmed, as the hormone is naturally synthesized by the placenta. Safety during lactation has not been established; therefore, nursing mothers should discuss potential risks and alternative approaches with their physician. In pediatric patients receiving treatment for cryptorchidism, therapy must be carefully supervised by a specialist to monitor skeletal development.

Common Questions

How long does ZyhCG remain detectable in the body after an injection?

Exogenous hCG is cleared from systemic circulation over several days, although residual amounts may remain detectable in serum or urine tests for up to two weeks post-injection. Because residual hCG can interfere with pregnancy testing by producing false-positive results, diagnostic testing should be interpreted according to your clinician’s timeline.

Is ZyhCG prescribed for weight reduction or metabolic enhancement?

No. Regulatory authorities explicitly state that human chorionic gonadotropin has no demonstrated effectiveness for weight loss, appetite control, or fat distribution. Using ZyhCG for weight loss is considered an unapproved off-label practice that lacks established clinical evidence.

What parameters should male patients monitor during extended ZyhCG therapy?

Male patients receiving long-term treatment should undergo periodic laboratory assessments, including serum testosterone levels, prostate-specific antigen (PSA), and hematocrit levels. Regular clinical exams help monitor for potential fluid retention or secondary androgenic effects like gynecomastia.

Can ZyhCG injections be self-administered at home?

Self-administration at home is permitted only after a healthcare professional provides comprehensive instructions on aseptic reconstitution techniques, syringe handling, and intramuscular injection protocols. Patients must strictly adhere to proper disposal procedures using a puncture-resistant sharps container.

Information on this page is for reference and does not replace an assessment by a licensed healthcare professional. In accordance with FDA requirements.

Additional information
Dosage

5000iu

Package

1 injection

,

2 injection

,

3 injection

,

4 injection

,

5 injection

,

6 injection

,

7 injection

,

8 injection

,

9 injection

,

10 injection

Ενεργός Ουσία